Table 3.

Specific Serious Adverse Events

	No. (%)
Type	Placebo	Ginkgo Biloba	HR (95% CI)	P Value
Death	188 (12.3)	197 (12.8)	1.04 (0.85–1.26)	.72
Bleeding, total	140 (9.2)	138 (8.9)	0.97 (0.77–1.23)	.81
Gastrointestinal	77 (5.1)	83 (5.4)	1.06 (0.78–1.45)	.70
All other	71 (4.7)	64 (4.1)	0.89 (0.64–1.25)	.52
CHD total	204 (13.4)	211 (13.7)	1.02 (0.84–1.24)	.83
Myocardial infarction	76 (5.0)	90 (5.8)	1.18 (0.87–1.59)	.30
Angina	99 (6.5)	107 (6.9)	1.06 (0.81–1.40)	.65
Angioplasty	65 (4.3)	79 (5.1)	1.20 (0.87–1.67)	.27
CABG	49 (3.2)	51 (3.3)	1.02 (0.69–1.52)	.90
CHD death	47 (3.1)	48 (3.1)	1.01 (0.67–1.50)	.98
Stroke, total	71 (4.7)	80 (5.2)	1.12 (0.81–1.54)	.50
Ischemic	62 (4.1)	62 (4.0)	0.99 (0.70–1.41)	.96
Hemorrhagic	8 (0.5)	16 (1.0)	1.97 (0.84–4.61)	.12
Unknown	2 (0.1)	3 (0.2)

Abbreviations: CABG, coronary artery bypass graft; CHD, coronary heart disease; CI, confidence interval; HR, hazard ratio.